1323-1333

Abstract. MMP-2 and MMP-9 secretion is elevated in several types of human cancers and their elevated expression has been associated with poor prognosis. Expression of MMPs is highly regulated by cytokines and signal transducation pathways, including those activated by phorbol 12-myristate 13-acetate (PMA). The aim of this study was to examine the effect of PMA on MMP-2 and MMP-9 secretion in 42 different human cancer cell lines, selected on the basis of their organ malignancies. They were cultured in the recommended media supplemented with 10% FBS and antibiotics in 24-well tissue culture plates. At near confluence, the cells were washed with PBS, 0.5 ml of medium was added, and the cultures were incubated. Parallel sets of cultures were also treated with PMA for induction of enzymes. After 24 h the media were collected and MMP-2 and MMP-9 levels were assayed by gelatinase zymography. Based on MMP-2 and MMP-9 secretion without and with PMA treatment, the various human cancer cell lines fell into one of two major groups. The first group characterized by low basal MMP-9 secretion fell into three different categories of susceptibility to PMA induction of MMP-9 expression: resistant, moderately susceptible and highly susceptible. High basal MMP-9 levels responsive to PMA induction characterized the second group. Most cancer cell lines examined exhibited basal levels of MMP-2, MMP-9 or both. MMP-2 secretion was not induced by PMA in any of the cancer cells examined

Right Scaling for Right Pricing: A Case Study on Total Cost of Ownership Measurement for Cloud Migration

Cloud computing promises traditional enterprises and independent software vendors a myriad of advantages over on-premise installations including cost, operational and organizational efficiencies. The decision to migrate software configured for on-premise delivery to the cloud requires careful technical consideration and planning. In this chapter, we discuss the impact of right-scaling on the cost modelling for migration decision making and price setting of software for commercial resale. An integrated process is presented for measuring total cost of ownership, taking in to account IaaS/PaaS resource consumption based on forecast SaaS usage levels. The process is illustrated with a real world case study

Social Internet of Things and New Generation Computing -- A Survey

Social Internet of Things (SIoT) tries to overcome the challenges of Internet of Things (IoT) such as scalability, trust and discovery of resources, by inspiration from social computing. This survey aims to investigate the research done on SIoT from two perspectives including application domain and the integration to the new computing models. For this, a two-dimensional framework is proposed and the projects are investigated, accordingly. The first dimension considers and classifies available research from the application domain perspective and the second dimension performs the same from the integration to new computing models standpoint. The aim is to technically describe SIoT, to classify related research, to foster the dissemination of state-of-the-art, and to discuss open research directions in this field.Comment: IoT, Social computing, Surve

Evaluation of appendicitis risk prediction models in adults with suspected appendicitis

Background Appendicitis is the most common general surgical emergency worldwide, but its diagnosis remains challenging. The aim of this study was to determine whether existing risk prediction models can reliably identify patients presenting to hospital in the UK with acute right iliac fossa (RIF) pain who are at low risk of appendicitis. Methods A systematic search was completed to identify all existing appendicitis risk prediction models. Models were validated using UK data from an international prospective cohort study that captured consecutive patients aged 16–45 years presenting to hospital with acute RIF in March to June 2017. The main outcome was best achievable model specificity (proportion of patients who did not have appendicitis correctly classified as low risk) whilst maintaining a failure rate below 5 per cent (proportion of patients identified as low risk who actually had appendicitis). Results Some 5345 patients across 154 UK hospitals were identified, of which two‐thirds (3613 of 5345, 67·6 per cent) were women. Women were more than twice as likely to undergo surgery with removal of a histologically normal appendix (272 of 964, 28·2 per cent) than men (120 of 993, 12·1 per cent) (relative risk 2·33, 95 per cent c.i. 1·92 to 2·84; P < 0·001). Of 15 validated risk prediction models, the Adult Appendicitis Score performed best (cut‐off score 8 or less, specificity 63·1 per cent, failure rate 3·7 per cent). The Appendicitis Inflammatory Response Score performed best for men (cut‐off score 2 or less, specificity 24·7 per cent, failure rate 2·4 per cent). Conclusion Women in the UK had a disproportionate risk of admission without surgical intervention and had high rates of normal appendicectomy. Risk prediction models to support shared decision‐making by identifying adults in the UK at low risk of appendicitis were identified

Micronutrient Synergy in the Fight against Hepatocellular Carcinoma

The incidence of hepatocellular carcinoma (HCC), once thought to be a rare tumor in North America, has rapidly increased in recent years in the United States. Current treatment modalities to halt the progression of this disease are only marginally effective. The mainstay treatment is liver transplantation, which is often confronted with donor shortage. Invasion, metastasis and recurrence contribute to the high mortality rate of this disease. Matrix metalloproteinases (MMPs) that degrade the extracellular matrix (ECM) have been associated with the progression, invasion and metastasis of the disease. We have developed strategies to strengthen the ECM collagen and inhibit MMPs through micronutrients such as lysine, proline and ascorbic acid. Addition of epigallocatechin gallate or green tea extract to these micronutrients synergistically enhanced anti-carcinogenic activity in HepG2 cells. Addition of certain other micronutrients, such as N-acetylcysteine, selenium, copper and zinc (NM) synergistically enhanced the anticancer activity of the mixture in a model of hepatocellular carcinoma using HepG2 cells. In vitro studies using HepG2 demonstrated that NM was very effective in inhibiting cell proliferation (by MTT assay), MMPs secretion (by gelatinase zymography), cell invasion (through Matrigel) and induction of apoptosis (by live green caspase). In addition, NM was shown to down-regulate urokinase plasminogen activator (by fibrin zymography) and up-regulate tissue inhibitors of metalloproteinases (by reverse zymography) in another HCC cell line, SK-Hep-1. MMP-2 and MMP-9 activities were further modulated by phorbol 12-myristate 13-acetate (PMA) induction and inhibited by NM. In previous studies, NM inhibited Sk-Hep-1 xenografts in nude mice and also inhibited hepatic metastasis of B16FO melanoma cells. Our results suggest that NM is an excellent candidate for therapeutic use in the treatment HCC by inhibiting critical parameters in cancer development and progression, such as proliferation, invasion and metastasis, and by inducing apoptosis

Morbosità da parto cesareo multiplo

Obiettivo: quantificare il rischio materno associato a parti cesarei (PC) multipli e determinare se il terzo cesareo definisce una soglia per l’aumento della morbosità. Metodi: dal gennaio 1997 al gennaio 2002, le cartelle cliniche relative a 3.191 donne che avevano partorito con taglio cesareo al nostro centro di riferimento ostetrico, sono state esaminate per alcuni indicatori scelti di morbosità materna. Le donne sono state assegnate a diversi gruppi in base al numero di PC, e la frequenza di ciascun indicatore è stata determinata. Per confrontare il rischio nei vari gruppi e rispetto al terzo cesareo, è stato poi ricavato, tra le donne raggruppate in base al numero di PC consecutivi, un punteggio composito per ogni indicatore. Risultati: sulla base di tutti gli indicatori studiati, la morbosità aumentava con i successivi PC fino a tutto il terzo. Rispetto a quest’ultimo, tuttavia, il rischio di morbosità importante risultava significativamente più elevato con il quinto, e molto peggio con il sesto per quanto riguarda placenta previa [odds ratio (OR) = 3,8; intervallo di confidenza al 95% (IC 95%) = 1,9-7,4], placente accreta (OR = 6,1; IC 95% = 2,0-18,4) e isterectomia (OR = 5,9; IC 95% = 1,5-24,4). Ma il terzo e il quarto PC comportavano lo stesso rischio di importante morbosità per placenta previa (OR = 1,4; IC 95% = 0,8-2,2), placenta accreta (OR = 1,0; IC 95% = 0,3- 2,9) e isterectomia (OR = 0,3; IC 95% = 0,0-2,7). Conclusioni: il terzo cesareo non definisce una soglia per l’aumento del rischio materno. La morbosità complessiva aumenta invece continuamente a ogni successivo PC. Tuttavia, in particolare per la morbosità importante dovuta alla triade placenta previa, placenta accreta e isterectomia durante il PC, il quarto PC comporta lo stesso rischio del terzo